.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

NEOSTIGMINE METHYLSULFATE Drug Profile

« Back to Dashboard
Neostigmine Methylsulfate is a drug marketed by Fresenius Kabi Usa and Eurohlth Intl Sarl and is included in two NDAs. It is available from four suppliers.

The generic ingredient in NEOSTIGMINE METHYLSULFATE is neostigmine methylsulfate. There are five drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the neostigmine methylsulfate profile page.

Summary for Tradename: NEOSTIGMINE METHYLSULFATE

Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list4
Drug Prices: :see details

Pharmacology for Tradename: NEOSTIGMINE METHYLSULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa
NEOSTIGMINE METHYLSULFATE
neostigmine methylsulfate
SOLUTION;INTRAVENOUS203629-001Jan 8, 2015RXNo► subscribe► subscribe
Eurohlth Intl Sarl
NEOSTIGMINE METHYLSULFATE
neostigmine methylsulfate
SOLUTION;INTRAVENOUS207042-002Dec 28, 2015RXNo► subscribe► subscribe
Fresenius Kabi Usa
NEOSTIGMINE METHYLSULFATE
neostigmine methylsulfate
SOLUTION;INTRAVENOUS203629-002Jan 8, 2015RXNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc